The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / It’s a Small World After All

It’s a Small World After All

September 1, 2007 • By Neal S. Birnbaum, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Neal S. Birnbaum, MD

The ACR has a role in advancing rheumatology and the care of the patients we treat both within and beyond the borders of the United States. Collaborative efforts across many functional areas without regard to geographic boundaries pay off for all members and for the profession as a whole.

You Might Also Like
  • It’s A Small World after All
  • A New Focus of International Rheumatology
  • The Pathway to Success
Explore This Issue
September 2007
Also By This Author
  • Reckoning of a Presidential Year

ILAR Revitalization and the ACR

The International League of Associations for Rheumatology (ILAR) is the umbrella organization for the four international leagues of rheumatology: the Panamerican League of Associations for Rheumatology (PANLAR), of which the ACR is a member; the European League Against Rheumatism (EULAR); the Asia Pacific League of Associations for Rheumatology; and the African League Against Rheumatism. ILAR’s mission includes education, epidemiology, international clinical studies, and pediatric rheumatology; it also publishes the journal Clinical Rheumatology. Although ILAR has a global focus, it concentrates on areas of the world with the greatest need.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

ILAR is currently undergoing a reorganization of its structure, governance, and programming. The new ILAR Executive Committee will consist of the president and president-elect of each of the four leagues and, in recognition of ACR’s status in the rheumatology community, the president and president-elect of the ACR. A strategic planning process is part of ILAR’s reorganization, although it is anticipated that interacting with the World Health Organization and meeting the needs of rheumatology in developing countries will continue to be core functions of ILAR. The new ILAR executive committee will meet in Boston this November, in conjunction with the ACR Annual Scientific Meeting, to further flesh out reorganization priorities.

Rheumatology societies exist at the local level – including in the communities of our nearly 1,500 members who live and work outside the United States – and help to advance issues of importance to the communities they serve. We can help make the worldwide community a better place for us all by forging a strong international organization with the cooperation of dozens of countries with the goal of improving rheumatology in those areas that need it most. I am honored that the ACR has been invited to play such an important role in the revitalization of this organization.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Global Disease Classification and Response Criteria

Ultimately, it is better for the scientific community, and therefore the patients we treat, if everyone can agree to one criteria set for a disease rather than a different one for each country or continent. We know, for example, that classification criteria are commonly used to determine which group of patients will be enrolled in trials for a particular disease. If the same criteria are used for two different trials, then the trials can be compared more easily. If two different sets of criteria are used, it’s harder to compare the trials because the populations might not match. Especially for those rheumatic diseases with small overall populations, we need to be able to define who actually has the disease so subjects from wide geographic areas can participate in collaborative trials. The same rationale applies to response criteria.

Pages: 1 2 3 | Single Page

Filed Under: Education & Training, Guidelines, President's Perspective Tagged With: A&R, AC&R, Classification Criteria, EULAR, ILAR, International, ResearchIssue: September 2007

You Might Also Like:
  • It’s A Small World after All
  • A New Focus of International Rheumatology
  • The Pathway to Success
  • The ACR’s Collaboration with International Rheumatology Associations Promotes Progress

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)